NA
LMAT icon

Navellier & Associates’s LeMaitre Vascular LMAT Stock Holding History

Navellier & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,019
Closed -$532K – 338
2021
Q3 		$532K Buy
+10,019
New +$564K 0.08% 186

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Navellier & Associates's LMAT Position: Q4 2021 in Review

Navellier & Associates sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 10,019 shares — an estimated $532K sold.

Navellier & Associates first reported a position in LMAT in Q3 2021 and held it in 1 quarter. The position peaked at $532K in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Navellier & Associates reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
  • Navellier & Associates sold 10,019 LeMaitre Vascular shares in Q4 2021, an estimated $532K.
  • Navellier & Associates first reported a position in LeMaitre Vascular in Q3 2021 and held it in 1 quarter.
  • Navellier & Associates's LeMaitre Vascular position peaked at $532K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Navellier & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.